Semaglutide 1.7mg in the Wegovy Titration Schedule

Step 1, How you arrive at 1.7mg (and why the journey matters)

Wegovy doesn't start at its therapeutic dose. The programme opens at 0.25mg, a level that does very little for weight on its own; its job is to let your digestive system get used to semaglutide before the doses that do the heavy lifting come into play. Each four-week block (0.5mg, then 1.0mg) is a deliberate step rather than a delay. By the time you reach 1.7mg you've already had three months of gradual adaptation, and the side-effect profile at this stage is typically milder than it was at the start.

This stepped approach is the reason Wegovy's five-dose schedule looks the way it does. The STEP 1 trial, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, but participants followed the same gradual escalation before arriving there. The 1.7mg stage is, in that sense, the preparation for the result rather than the result itself.

Your prescriber decides when (and whether) to move from 1.0mg to 1.7mg. If nausea or other gastrointestinal symptoms were difficult at the previous dose, they may extend the time at 1.0mg, and our semaglutide 1 mg guidance explains what to expect while you spend longer at that stage. That isn't a setback; it's the titration working as intended.

Step 2, What changes at 1.7mg compared with earlier doses

Most people notice a more pronounced reduction in appetite at 1.7mg than at 1.0mg. Gastric emptying slows further, meals feel more filling, and the urge to snack between them tends to fall. For some patients this is the dose where weight loss visibly accelerates; for others the shift is more gradual and builds across the four weeks.

Side effects at 1.7mg broadly mirror those at earlier stages (nausea, loose stools, constipation, reflux and fatigue are the most commonly reported) but their intensity varies between individuals. They tend to be most noticeable in the first week after a dose increase and ease as the body adapts. Staying well hydrated, eating smaller portions and avoiding very fatty meals helps. The NHS semaglutide medicines page lists the full side-effect profile and sets out which symptoms need prompt medical attention.

One practical note that patients sometimes overlook: Wegovy pens are refrigerated, stored between 2°C and 8°C. Keeping the current pen in the fridge door rather than the back of the shelf makes the weekly routine easier to stick to. The Patient Information Leaflet covers exactly how long a pen can be kept at room temperature if you're travelling, always follow that, not a general figure.

Step 3 (The move from 1.7mg to 2.4mg, and what happens then

After four weeks at 1.7mg, the standard schedule moves to 2.4mg) the licensed maintenance dose for weight management. This is where long-term treatment continues, subject to ongoing clinical review. If 1.7mg is already causing significant side effects, your prescriber may decide to maintain that dose rather than increase, since 1.7mg can be used as an alternative maintenance dose where 2.4mg is not tolerated. That decision is made individually; it isn't something to self-manage.

It's also worth knowing that a higher 7.2mg dose of Wegovy was approved by the MHRA in January 2026, with a dedicated single-dose pen confirmed in April 2026. Whether that becomes relevant for you is a longer-term clinical conversation. For now, the 2.4mg stage is the immediate horizon from 1.7mg. The dose guidance for weight management covers how maintenance is assessed over time.

Wegovy is a prescription-only medicine. At every stage (including the step from 1.7mg to 2.4mg) a prescriber reviews your progress. That review is the safeguard, not a formality. If you're considering private treatment and want to understand what a clinical assessment involves, our Wegovy overview walks through the process, and our treatment pricing page explains what's included in a single transparent cost. If you have questions before starting, our FAQs cover the questions prescribers hear most often.

Check your eligibility by starting a free consultation with our prescribers at our weight-loss treatments page, a real clinician reads every submission the same day.